Pfizer

Multinational pharmaceutical corporation

Pfizer ▸ Facts ▸ Comments ▸ News ▸ Videos

Pfizer Inc. is an American multinational pharmaceutical corporation. Pfizer is one of the world's largest pharmaceutical companies, and was ranked 64th on the 2020 Fortune 500 list of the largest U.S. corporations by total revenue, at $51.75 billion.

0 shares	Share Tweet Save Post Send


Minister: Government following ‘clear advice’ over vaccines Communities Secretary Robert Jenrick has insisted that the government is "following the very clear advice" from medical leaders when questioned on the decision administer the second Pfizer-BioNTech jab.. Credit: ODN Duration: 00:42Published 2 days ago

BMA calls for gap between Covid vaccination to be halved Dr Chaand Nagpaul, chair of the British Medical Association has called for the maximum time period between people receiving their first and second Pfizer-BioNTech Covid-19 vaccinations to be cut from.. Credit: ODN Duration: 00:59Published 2 days ago


Pfizer to join WHO co-led vaccine scheme: sources Pfizer and BioNTech have agreed to supply their COVID-19 vaccine to the World Health Organization co-led COVAX vaccine access scheme, two sources familiar with the deal said, the latest in a series of.. Credit: Reuters Studio Duration: 01:40Published 3 days ago

COVID vaccinations: Second shot delays not recommended by global health chiefs International organisations are calling any breaks between the Pfizer/BioNTech vaccine doses not to be extended beyond 21 days. Both Pfizer and Moderna also do not support the delay strategy touted by.. Credit: Euronews English Duration: 02:38Published 4 days ago

Pfizer vaccine appears effective against UK variant The COVID-19 vaccine developed by Pfizer and BioNTech is likely to protect against a more infectious variant of the virus, which was discovered in Britain and has spread around the world, according to.. Credit: Reuters Studio Duration: 01:15Published 5 days ago

Some nations unable to make most of Pfizer shots Switzerland, France and Germany say they're struggling to get the recommended six shots out of each vial of vaccine made by Pfizer and BioNTech, potentially slowing the rollout of inoculations. Julian.. Credit: Reuters Studio Duration: 01:15Published 6 days ago

Norway: No link established after post-COVID-19 vaccination deaths, says health authority Norway has stressed that there was no established link between the Pfizer/BioNTech COVID-19 vaccine and the deaths of elderly people who had been vaccinated. Credit: euronews (in English) Duration: 02:39Published 6 days ago

CDC warns new Covid-19 variants could accelerate spread in US CNN’s Erica Hill reports on confusion around the amount of second doses of the coronavirus vaccine from Pfizer as the CDC warns the new Covid-19 variants could accelerate the spread of Covid-19 in.. Credit: Bleacher Report AOL Duration: 02:15Published 1 week ago

Pfizer Vaccine Shortage Credit: FRANCE 24 English Duration: 05:54Published 1 week ago

Vaccine manufacturing is lumpy, UK says Britain's vaccine rollout is limited by a "lumpy" manufacturing process with production changes by Pfizer and a delay by AstraZeneca that could lead to brief supply disruption, Vaccine Deployment.. Credit: Reuters Studio Duration: 01:24Published 1 week ago

Easing of lockdown restrictions not before March, says Zahawi Vaccines minister Nadhim Zahawi has suggested that a gradual easing oflockdown restrictions will not begin before early March. He told BBCBreakfast: “If we take the mid-February target, two weeks.. Credit: PA - Press Association STUDIO Duration: 00:53Published 1 week ago

Phase 3 trial of Pfizer, Moderna underway, benefits are overwhelming compared to risk: VK Paul NITI Aayog Member (Health) Dr VK Paul said that phase 3 trial of Pfizer, Moderna is still going on but the benefits are overwhelming compared to risk. "World has decided to move forward, take benefit.. Credit: ANI Duration: 01:14Published 1 week ago

COVID vaccines: Six EU countries hit out at 'unacceptable' delays to deliveries of Pfizer jab "Fewer doses will be available for European countries at the end of January and the beginning of February," said Pfizer. Credit: Euronews English Duration: 03:40Published 1 week ago

Pfizer Study Suggests COVID Vaccine Works Against Different Strains Pfizer and researchers from the University of Texas Medical Branch in Galveston teamed up for the study. Credit: Cover Video STUDIO Duration: 01:06Published 2 weeks ago

Coronavirus pandemic: EU doubles BioNTech/Pfizer vaccine order to 600 million doses Credit: FRANCE 24 English Duration: 01:45Published 2 weeks ago

5 cosas: UE compra más vacunas y SpaceX realiza primer lanzamiento de 2021 En el Reino Unido, el gobierno pedirá pruebas obligatorias de covid-19 para todas las personas que lleguen desde el exterior. La Unión Europea comprará hasta 300 millones de vacunas adicionales de.. Credit: Bleacher Report AOL Duration: 02:19Published 2 weeks ago

UK approves its third COVID-19 vaccine as regulator gives green light to Moderna jab Moderna's shot is easier to handle than the Pfizer vaccine because it doesn't need to be stored at ultra-frozen temperatures. Credit: Euronews English Duration: 01:14Published 2 weeks ago

EU doubles COVID vaccine deal with Pfizer The European Union reached a deal with Pfizer and BioNTech for 300 million additional doses of their COVID-19 vaccine, the head of the European Commission said on Friday, in a move that would give the.. Credit: Reuters Studio Duration: 01:17Published 2 weeks ago

EU double order of Pfizer jab enough to vaccinate 380 million Europeans European Commission president Ursula von der Leyen has announced that the EUhas reached a deal to order 300 million extra doses of the BioNTech-PfizerCovid-19 vaccine, doubling the amount that will be.. Credit: PA - Press Association STUDIO Duration: 01:21Published 2 weeks ago

Pfizer Covid-19 vaccine ‘works against rapid spread mutant strains’ The Covid-19 vaccine from Pfizer and BioNTech protects against two new mutantvariants that are causing rapid spread across the UK, new research suggests.The pharmaceutical giant and researchers from.. Credit: PA - Press Association STUDIO Duration: 00:30Published 2 weeks ago

You Might Like

Halve the gap between vaccine doses, senior doctors urge Senior doctors have called on England's chief medical officer to halve the gap between the first and second doses of the Pfizer coronavirus vaccine. Sky News - Published 3 days ago
UK to look 'very carefully' at vaccine dosing after concerns over level of protection The UK will need to look "very carefully" at the protection provided by the Pfizer/BioNTech vaccine, the government's chief scientific adviser has told Sky News, amid concerns its effectiveness is.. Sky News - Published 5 days ago
'Real-world' analysis of COVID vaccine raises questions about UK strategy The first real-world analysis of the Pfizer coronavirus vaccine suggests it is matching its performance in clinical trials, but raises serious questions about the UK's decision to delay the second.. Sky News - Published 6 days ago

Pfizer to cut COVID vaccine deliveries as it upgrades production facility Pfizer has confirmed it is planning to temporarily slow deliveries of its coronavirus vaccine to Europe while it focuses on upscaling its manufacturing facilities. Sky News - Published 1 week ago
Pfizer delay will not stop UK from vaccinating top priority groups by mid-February, government says The government says that it is still planning to vaccinate the top four priority groups by mid-February, despite expected production delays for the Pfizer vaccine. Sky News - Published 1 week ago
India wants Pfizer to do local study for approval: Official IndiaTimes - Published 2 weeks ago

Vaccine boost for EU with medics now allowed to draw six doses from single Pfizer vial The European Union's drug agency is now allowing doctors to draw up to six doses from each vial of the Pfizer/BioNTech vaccine. Sky News - Published 2 weeks ago
Concern over COVID variant but Pfizer research suggests jab still effective Concern has been raised about how effective coronavirus vaccines are against the new South African variant, but new research from Pfizer suggests its jab may still work. Sky News - Published 2 weeks ago
Covaxin can offer protection against mutated coronavirus: Bharat Biotech Vaccine makers like Pfizer and AstraZeneca have also said that their vaccines against Covid-19 should work against the new strain. DNA - Published on December 30, 2020
AOC Marvelously Explains What COVID Vaccine Does, Gets Shot Herself Rep. Alexandria Ocasio-Cortez just gave an awesome break-down of what's in the COVID vaccine, what it'll do and how it works ... this after getting the shot herself. The New York Congresswoman hopped.. TMZ.com - Published on December 20, 2020

COVID vaccine distribution requires funding of Rs 80,000 crore, says Serum Institute of India Serum Institute-Oxford's Covishield, Bharat Biotech's Covaxin and Pfizer vaccine are in the fray for emergency use authorization. DNA - Published on December 19, 2020
Pfizer Says Millions of COVID Vaccine Doses Are Sitting in a Warehouse Pfizer says it's sitting on liquid gold -- a warehouse packed with the COVID-19 vaccine -- but it can't get word from the government on where to ship them. The pharma giant made the shocking revelation.. TMZ.com - Published on December 18, 2020
Pfizer Study Patient Says 2nd Vaccine Shot Hits Hard, 'Really Sick' but Not for Long People who are getting the coronavirus vaccine don't know what's coming next -- that 2nd shot could hit like a ton of bricks, according to a guy who volunteered for Pfizer's study. Eric Gross joined us.. TMZ.com - Published on December 17, 2020	Pfizer Offering Placebo Patients Vaccine, Letting Them Jump the Line Membership has its benefits -- people who participated in Pfizer's vaccine trial, but only got the placebo, now have the chance to get the real vaccine earlier ... TMZ has learned. Sources with direct.. TMZ.com - Published on December 17, 2020
Covid-19 vaccine pricing to help govts to ensure little to no out-of-pocket costs for people: Pfizer IndiaTimes - Published on December 17, 2020	Vaccine deals: India, Oxford numbers see dip, but still on top; Pfizer gains most IndiaTimes - Published on December 13, 2020
Pfizer Begins Shipping COVID Vaccines by FedEx and UPS These images could foretell the end of the pandemic -- trucks have never looked so awesome!!! FedEx and UPS trucks rolled out of Pfizer's Kalamazoo, Michigan parking lot, carrying massive amounts of.. TMZ.com - Published on December 13, 2020	India readies for 60 crore COVID vaccine jabs; to use standard cold storage Indian regulators are considering 3 vaccines for emergency use authorisation, including those from Pfizer Inc, AstraZeneca and Bharat Biotech. DNA - Published on December 12, 2020
Pfizer Applies for Trademark for New Catchphrase in Marketing COVID Vaccine Pfizer is in inevitable competition with the other drug companies that are developing COVID vaccines, and it's apparently trying to get a jump on its competitors with a new catchphrase. The.. TMZ.com - Published on December 10, 2020	Covid-19 vaccine to have differential pricing: Pfizer "We are having a tier pricing. It is one price for the developed world based on their GDP, another price, lower for the middle-income countries and in the low-income countries, like countries in Africa.. IndiaTimes - Published on December 9, 2020
3 Covid-19 vaccine candidates under active consideration of drug regulator: Health ministry Three Covid-19 vaccines candidates, developed by Bharat Biotech, Serum Institute of India and Pfizer, are under active consideration of India's drug regulator and there is hope that early licensure is.. IndiaTimes - Published on December 8, 2020	Covid-19: Day after Serum Institute of India, Bharat Bio seeks emergency nod for vaccine Hyderabad-based Bharat Biotech filed an application seeking emergency use authorisation for Covaxin on Monday, becoming the third company to seek such regulatory approval in India after Pfizer and.. IndiaTimes - Published on December 7, 2020
Bharat Biotech seeks emergency use authorisation for indigenously developed Covid-19 vaccine Covaxin After Pfizer and Serum Institute, Hyderabad-based pharmaceutical firm Bharat Biotech on Monday applied to the central drug regulator seeking emergency use authorisation for its Covid-19 vaccine.. IndiaTimes - Published on December 7, 2020	India speeding up review of Pfizer, Astra Covid-19 vaccines: Govt official India is accelerating its review of coronavirus vaccines developed by Pfizer Inc and AstraZeneca for emergency use, a senior government official said on Monday, as the world's second-most affected.. IndiaTimes - Published on December 7, 2020
Pfizer becomes first pharma company in India to seek emergency use nod for its Covid-19 vaccine Pfizer India has become the first pharmaceutical firm to approach the Drugs Controller General of India (DCGI) seeking an emergency use authorisation for its Covid-19 vaccine in the country. It is to.. IndiaTimes - Published on December 6, 2020	COVID-19: Pfizer seeks emergency use authorisation for its vaccine in India In its application to DCGI, the company has requested approval for the import and distribution of vaccines in India. DNA - Published on December 6, 2020
Pfizer seeks emergency use nod in India IndiaTimes - Published on December 5, 2020	In talks with India on opportunity to roll out vaccine: Pfizer IndiaTimes - Published on December 3, 2020
Sputnik’s ‘efficacy at 95%’, to be cheaper than US vaccines Russia’s Sputnik V Covid-19 vaccine, that reported an efficacy of over 95%, will be twice as cheap as those by Pfizer and Moderna with similar positive results. Sputnik V, developed by Gamaleya.. IndiaTimes - Published on November 24, 2020	After Pfizer and Moderna, Oxford-AstraZeneca claims 90% efficacy of COVID-19 vaccine According to the Oxford University release, no volunteer complained of any medical issue during the trial of the vaccine. DNA - Published on November 23, 2020
Storage of Pfizer's Covid vaccine challenge for most nations; India examining possibilities: Govt The cold-chain requirement for the anti-coronavirus vaccine candidate developed by Pfizer at a temperature of minus 70 degrees Celsius poses a big challenge, but the govt is working out a strategy for.. IndiaTimes - Published on November 17, 2020	India pins hopes on locally-tested Covid-19 vaccines given Pfizer constraints IndiaTimes - Published on November 17, 2020
Moderna Says its COVID-19 Vaccine is 94.5% Effective COVID-19 is about to get tag-teamed -- a second vaccine is on the way, and Moderna says this one has an even higher success rate than the first. On the heels of Pfizer's announcement it has a.. TMZ.com - Published on November 16, 2020	Pfizer vaccine results leave questions about safety, longevity IndiaTimes - Published on November 14, 2020
Keeping Pfizer's Covid-19 vaccine at low temperatures will be challenging for India, others: AIIMS Director Dr Randeep Guleria, Director, All India Institute of Medical Sciences Delhi (AIIMS), Delhi on Wednesday said the results of Pfizer's Covid-19 vaccine phase III trials are very encouraging but.. IndiaTimes - Published on November 11, 2020	Decision on Pfizer's Covid-19 vaccine will be based on regulatory approval: Centre IndiaTimes - Published on November 11, 2020
Coronavirus vaccine: Centre in talks with Pfizer to make vaccine available for use in India On Monday, Pfizer Inc and BioNTech SE announced more than 90% efficacy of their potential vaccine for the coronavirus infection. DNA - Published on November 11, 2020	India in talks with all Covid vaccine manufacturers, domestic and foreign: Health ministry A day after Pfizer Inc and BioNTech SE announced more than 90 per cent efficacy of their potential vaccine for the coronavirus, the health ministry on Tuesday said the National Expert Group on Vaccine.. IndiaTimes - Published on November 10, 2020
Vaccine Expert Peter Hotez Says Pfizer Vaccine Creates New Challenges Buzzkill alert -- Dr. Peter Hotez is serving up a test tube full of very cautious optimism about Pfizer's huge coronavirus vaccine announcement. The renowned vaccine expert joined "TMZ Live" Monday to.. TMZ.com - Published on November 9, 2020	Pfizer Develops COVID Vaccine That's More than 90 Percent Effective At last!!! It looks like a COVID vaccine is on the horizon that will change the world. Pfizer just released incredible data -- preliminary though it is -- showing they've developed a vaccine that is.. TMZ.com - Published on November 9, 2020
Congress seeks CBI probe into Kerala Covid-19 data deal Even as Kerala CM Pinarayi Vijayan continues to maintain that all was fair in the transfer of coronavirus data to US-based Sprinklr, a Congress leader on Monday, demanded a CBI probe into it after.. IndiaTimes - Published on April 20, 2020	Pfizer identified some antiviral compounds with potential as coronavirus treatments Drugmaker Pfizer Inc said on Monday that it identified certain antiviral compounds it had in development that have the potential to inhibit coronaviruses and is engaging with a third party to screen.. Reuters - Published on March 2, 2020

Pfizer

Multinational pharmaceutical corporation

Pfizer ▸ Facts ▸ Comments ▸ News ▸ Videos

You Might Like

Halve the gap between vaccine doses, senior doctors urge

UK to look 'very carefully' at vaccine dosing after concerns over level of protection

'Real-world' analysis of COVID vaccine raises questions about UK strategy

Pfizer to cut COVID vaccine deliveries as it upgrades production facility

Pfizer delay will not stop UK from vaccinating top priority groups by mid-February, government says

India wants Pfizer to do local study for approval: Official

Vaccine boost for EU with medics now allowed to draw six doses from single Pfizer vial

Concern over COVID variant but Pfizer research suggests jab still effective

Covaxin can offer protection against mutated coronavirus: Bharat Biotech

AOC Marvelously Explains What COVID Vaccine Does, Gets Shot Herself

COVID vaccine distribution requires funding of Rs 80,000 crore, says Serum Institute of India

Pfizer Says Millions of COVID Vaccine Doses Are Sitting in a Warehouse

Pfizer Study Patient Says 2nd Vaccine Shot Hits Hard, 'Really Sick' but Not for Long

Pfizer Offering Placebo Patients Vaccine, Letting Them Jump the Line

Covid-19 vaccine pricing to help govts to ensure little to no out-of-pocket costs for people: Pfizer

Vaccine deals: India, Oxford numbers see dip, but still on top; Pfizer gains most

Pfizer Begins Shipping COVID Vaccines by FedEx and UPS

India readies for 60 crore COVID vaccine jabs; to use standard cold storage

Pfizer Applies for Trademark for New Catchphrase in Marketing COVID Vaccine

Covid-19 vaccine to have differential pricing: Pfizer

3 Covid-19 vaccine candidates under active consideration of drug regulator: Health ministry

Covid-19: Day after Serum Institute of India, Bharat Bio seeks emergency nod for vaccine

Bharat Biotech seeks emergency use authorisation for indigenously developed Covid-19 vaccine Covaxin

India speeding up review of Pfizer, Astra Covid-19 vaccines: Govt official

Pfizer becomes first pharma company in India to seek emergency use nod for its Covid-19 vaccine

COVID-19: Pfizer seeks emergency use authorisation for its vaccine in India

Pfizer seeks emergency use nod in India

In talks with India on opportunity to roll out vaccine: Pfizer

Sputnik’s ‘efficacy at 95%’, to be cheaper than US vaccines

After Pfizer and Moderna, Oxford-AstraZeneca claims 90% efficacy of COVID-19 vaccine

Storage of Pfizer's Covid vaccine challenge for most nations; India examining possibilities: Govt

India pins hopes on locally-tested Covid-19 vaccines given Pfizer constraints

Moderna Says its COVID-19 Vaccine is 94.5% Effective

Pfizer vaccine results leave questions about safety, longevity

Keeping Pfizer's Covid-19 vaccine at low temperatures will be challenging for India, others: AIIMS Director

Decision on Pfizer's Covid-19 vaccine will be based on regulatory approval: Centre

Coronavirus vaccine: Centre in talks with Pfizer to make vaccine available for use in India

India in talks with all Covid vaccine manufacturers, domestic and foreign: Health ministry

Vaccine Expert Peter Hotez Says Pfizer Vaccine Creates New Challenges

Pfizer Develops COVID Vaccine That's More than 90 Percent Effective

Congress seeks CBI probe into Kerala Covid-19 data deal

Pfizer identified some antiviral compounds with potential as coronavirus treatments